OFIX — Orthofix Medical Cashflow Statement
0.000.00%
- $553.73m
- $646.10m
- $799.49m
- 65
- 69
- 89
- 88
Annual cashflow statement for Orthofix Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.52 | -38.4 | -19.7 | -151 | -126 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 10.7 | 27.5 | 8.11 | 106 | 109 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 19.7 | -24.7 | -29.2 | -54 | -19.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 74.3 | 18.5 | -11.5 | -45.8 | 25.8 |
Capital Expenditures | -24.3 | -20.8 | -24.5 | -62 | -34.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -28 | -2.17 | 0 | 28.9 | 7.3 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -52.3 | -23 | -24.5 | -33.1 | -27.6 |
Financing Cash Flow Items | -4.03 | -11.9 | -1.82 | -7.75 | -9.94 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.25 | -3.62 | -0.078 | 65.3 | 50.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 26.4 | -8.97 | -37.1 | -12.9 | 48 |